Virtu Financial LLC Invests $46,000 in Quantum Biopharma Ltd. (NASDAQ:QNTM)

Virtu Financial LLC acquired a new position in shares of Quantum Biopharma Ltd. (NASDAQ:QNTM) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 11,428 shares of the company’s stock, valued at approximately $46,000.

Quantum Biopharma Stock Down 13.3 %

NASDAQ:QNTM opened at $3.00 on Friday. Quantum Biopharma Ltd. has a 52 week low of $2.70 and a 52 week high of $70.85. The stock’s fifty day moving average price is $4.92. The firm has a market capitalization of $5.76 million, a PE ratio of -0.19 and a beta of 0.59.

Quantum Biopharma Profile

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments.